ABSTRACT
Therapeutic education is defined as all the tools taught to patients with the aim of improving their compliance to treatments. In a chronic disease, such as cystic fibrosis, this education should be done during the first months of child's life with the collaboration of parents and then gradually given to children from the age of 6 until they are autonomous in the management of their treatment during adolescence. The tools used for therapeutic education should be playful, varied and adapted to the child's development, while respecting a standard for competences. In this article, we will define the main approaches of therapeutic education in patients with cystic fibrosis.
L'éducation thérapeutique se définit comme l'ensemble des outils enseignés aux patients dans le but d'améliorer leur adhésion aux traitements. Lors d'une maladie chronique, telle que la mucoviscidose, cet appren¬tissage doit être réalisé dès les premiers mois de vie de l'enfant avec ses parents. Elle se transmet ensuite progres¬sivement vers l'enfant à partir de l'âge de 6 ans afin de l'au¬tonomiser à l'adolescence. Les moyens aidant à réaliser cette éducation thérapeutique doivent être ludiques, variés et adaptés au développement de l'enfant, tout en respec¬tant un référentiel de compétences. Dans cet article, nous retraçons les grandes lignes de l'éducation thérapeutique dans la prise en charge de la mucoviscidose.
Subject(s)
Cystic Fibrosis , Adolescent , Child , Chronic Disease , Cystic Fibrosis/therapy , Humans , Parents , Patient ComplianceABSTRACT
The authors present the results of a retrospective study concerning 231 magnetic resonance imaging (MRI) of the cerellopontine space requested by the otologists of the department between September 1996 and September 1997. The motives of imaging were sensorineural hearing loss (44%), vertigo and unsteadiness (25.5%), tinnitus (16.5%) and other (13%). The MRI was abnormal in 18% of the cases and the diagnosis of acoustic schwannoma was made in 10% of the cases.
